Early events of HIV-1 infection: can signaling be the next therapeutic target?
- PMID: 21373988
- DOI: 10.1007/s11481-011-9268-5
Early events of HIV-1 infection: can signaling be the next therapeutic target?
Abstract
Intracellular signaling events are signposts of biological processes, which govern the direction and action of biological activities. Through millions of years of evolution, pathogens, such as viruses, have evolved to hijack host cell machinery to infect their targets and are therefore dependent on host cell signaling for replication. This review will detail our current understanding of the signaling events that are important for the early steps of HIV-1 replication. More specifically, the therapeutic potential of signaling events associated with chemokine coreceptors, virus entry, viral synapses, and post-entry processes will be discussed. We argue that these pathways may represent novel targets for antiviral therapy.
Similar articles
-
Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.Biochem Pharmacol. 2016 Apr 15;106:30-45. doi: 10.1016/j.bcp.2016.02.002. Epub 2016 Feb 4. Biochem Pharmacol. 2016. PMID: 26851491
-
Virus maturation as a new HIV-1 therapeutic target.Expert Opin Ther Targets. 2009 Aug;13(8):895-908. doi: 10.1517/14728220903039714. Expert Opin Ther Targets. 2009. PMID: 19534569 Free PMC article. Review.
-
"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.Drug Deliv. 2017 Nov;24(1):608-621. doi: 10.1080/10717544.2016.1228717. Drug Deliv. 2017. PMID: 28240046 Free PMC article. Review.
-
Inhibition of HIV-1 entry: multiple keys to close the door.ChemMedChem. 2010 Nov 8;5(11):1825-35. doi: 10.1002/cmdc.201000292. ChemMedChem. 2010. PMID: 20845361 Review. No abstract available.
-
Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism.J Neuroimmune Pharmacol. 2011 Jun;6(2):284-95. doi: 10.1007/s11481-011-9274-7. Epub 2011 Mar 29. J Neuroimmune Pharmacol. 2011. PMID: 21445582 Free PMC article. Review.
Cited by
-
RNA Structures and Their Role in Selective Genome Packaging.Viruses. 2021 Sep 8;13(9):1788. doi: 10.3390/v13091788. Viruses. 2021. PMID: 34578369 Free PMC article. Review.
-
Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1.J Virol. 2017 Jun 9;91(13):e02418-16. doi: 10.1128/JVI.02418-16. Print 2017 Jul 1. J Virol. 2017. PMID: 28381571 Free PMC article.
-
Quantitative phosphoproteomics of CXCL12 (SDF-1) signaling.PLoS One. 2011;6(9):e24918. doi: 10.1371/journal.pone.0024918. Epub 2011 Sep 20. PLoS One. 2011. PMID: 21949786 Free PMC article.
-
Cell signaling pathways and HIV-1 therapeutics.J Neuroimmune Pharmacol. 2011 Jun;6(2):173-6. doi: 10.1007/s11481-011-9275-6. Epub 2011 Mar 30. J Neuroimmune Pharmacol. 2011. PMID: 21448593
-
Co-receptor signaling in the pathogenesis of neuroHIV.Retrovirology. 2021 Aug 24;18(1):24. doi: 10.1186/s12977-021-00569-x. Retrovirology. 2021. PMID: 34429135 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical